Tazemetostat Expanded Access Program for Adults With Solid Tumors

Clinical trial NCT03874455 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03874455
Sponsor: Epizyme, Inc.
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Epithelioid Sarcoma (Ex-US Only)Spindle Cell Sarcoma Sinonasal Carcinoma Small Cell Carcinoma of the Ovary Hypercalcemic Type Thoracic Sarcoma Poorly Differentiated Chordoma ATRT Malignant Rhabdoid Tumor of Kidney Malignant Rhabdoid Tumor of Ovary Malignant Rhabdoid Tumor Myxoid Spindle Cell Sarcoma Epithelioid Malignant Peripheral Nerve Sheath Tumor

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.